Quinolinic acid toxicity on oligodendroglial cells: relevance for multiple sclerosis and therapeutic strategies.
about
Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple SclerosisKynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous SystemQuinolinic Acid Responses during Interferon-α-Induced Depressive Symptomatology in Patients with Chronic Hepatitis C Infection - A Novel Aspect for Depression and Inflammatory HypothesisExpression of the Kynurenine Pathway in Human Peripheral Blood Mononuclear Cells: Implications for Inflammatory and Neurodegenerative DiseaseExcitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis.3-hydroxi-anthranilic acid is early expressed in stroke.Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progressionBeta-trace Protein as a new non-invasive immunological Marker for Quinolinic Acid-induced impaired Blood-Brain Barrier Integrity.Cannabinoids: Glutamatergic Transmission and Kynurenines.Tryptophan Metabolism and White Matter Integrity in Schizophrenia.Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple Sclerosis.Microglia activation contributes to quinolinic acid-induced neuronal excitotoxicity through TNF-α.An Expanded Neuroimmunomodulation Axis: sCD83-Indoleamine 2,3-Dioxygenase—Kynurenine Pathway and Updates of Kynurenine Pathway in Neurologic Diseases.Intraventricular infusion of quinolinic acid impairs spatial learning and memory in young rats: a novel mechanism of lead-induced neurotoxicity
P2860
Q26740330-17E2A254-6F63-4F5F-B877-3CD6D8D626E4Q26796667-10ACDD18-A8E2-461D-8431-2A0E35B199B8Q28607691-3D8CD7AD-AD06-47DE-B679-45B47799C139Q35788146-880B4DBD-2353-46EB-9380-A7C3455636E2Q36283207-A2398693-5789-4A45-887C-D04A4CC2FB11Q37508208-16367A3A-6936-4B5C-8150-7B3E2EA2665CQ37623145-7D5485BE-8FA5-4ED6-A820-D817A548FC7AQ37690195-F94B1D5E-732E-436C-BC20-280E2ED22E5AQ38819251-C9715C85-593D-443C-A79B-254059C2DAD1Q41725053-2B346BB1-9239-4D56-A2EF-A1AA00777615Q46496773-0E924E53-E379-4B2D-B682-71289A55EB4EQ51834808-09A561F8-D3D8-4118-9D68-652985A0F235Q55381445-268FE6F8-84FA-41B0-A745-AF13157DAFBDQ58741780-AC551169-EB92-4E80-B504-A845391366D6
P2860
Quinolinic acid toxicity on oligodendroglial cells: relevance for multiple sclerosis and therapeutic strategies.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Quinolinic acid toxicity on ol ...... is and therapeutic strategies.
@ast
Quinolinic acid toxicity on ol ...... is and therapeutic strategies.
@en
Quinolinic acid toxicity on ol ...... is and therapeutic strategies.
@nl
type
label
Quinolinic acid toxicity on ol ...... is and therapeutic strategies.
@ast
Quinolinic acid toxicity on ol ...... is and therapeutic strategies.
@en
Quinolinic acid toxicity on ol ...... is and therapeutic strategies.
@nl
prefLabel
Quinolinic acid toxicity on ol ...... is and therapeutic strategies.
@ast
Quinolinic acid toxicity on ol ...... is and therapeutic strategies.
@en
Quinolinic acid toxicity on ol ...... is and therapeutic strategies.
@nl
P2860
P50
P1476
Quinolinic acid toxicity on ol ...... is and therapeutic strategies.
@en
P2093
Gayathri Sundaram
Simon P Jones
P2860
P2888
P356
10.1186/S12974-014-0204-5
P577
2014-12-13T00:00:00Z
P5875
P6179
1018878417